The Core Curriculum for Medical Communications Professionals Practicing in the Pharmaceutical Industry
- PDF / 1,069,578 Bytes
- 14 Pages / 504 x 719.759 pts Page_size
- 84 Downloads / 181 Views
0092-8615/2000 Copyright 0 2000 Drug Infomiation Association Inc.
THE CORE CURRICULUM FOR MEDICAL COMMUNICATIONS PROFESSIONALS PRACTICING IN THE PHARMACEUTICAL INDUSTRY DAVIDA. GRAVES,PHARMD Business Development Executive PPD ATP, Durham, North Carolina, and Assistant Clinical Professor, University of California San Francisco, School of Pharmacy, San Francisco, California
ROBERTP. BAKER,FHARMD Director, Roche Pharmaceutical Services Center and Professional Product Information, Roche Laboratories. Inc., Nutley, New Jersey
This article provides the instructor’s notes for the Drug Information Association’s (DIAS) Core Curriculum in Medical Communications. The Core Curriculum is a standing educational program sponsored by the Medical Communications Special Interest Section of the DIA. It has been presented annually at the Medical Communications Workshop since 1996 and is offered as a tutorial at the DIA Annual Meeting. The Core Curriculum in Medical Communications is designed for those who are new to industry-based drug information in the United States. It encompasses the key activities of industry-based drug information practice, highlights the key differences between industry-based and nonindustry-based information practice, and encourages new practitioners to seek advice from experienced colleagues. Key Words: Medical communications; DIA Core Curriculum; Industry-based drug information
MOST PHARMACEUTICAL AND biotechnology companies now recognize that providing product information to health care professionals and patients is not only “good public relations” but is also good business. The Food and Drug Administration (FDA) acknowledges that this type of service is important because it supports health care professionals with their day-to-day care of patients. Such service also supports patients who, in ever-increasing numbers, seek prod-
Reprint address: David A. Graves, PharmD, Business Development Executive, PPD ATP, 2655 Meridian Parkway, Durham, NC 27713. E-mail: [email protected].
uct information directly from the manufacturer as well as from their health care professionals. Today, most pharmaceutical and biotechnology companies have employed health care professionals who, over the years, have developed a new specialty practice area based on the drug information practice guidelines of the American Society of Health-System Pharmacists, FDA guidelines for handling unsolicited inquiries from health care professionals, company policies, and personal and professional ethics. Some companies now sponsor postdoctoral drug information residency programs to better prepare future drug information practitioners for a career in industry-based drug information practice.
995
Downloaded from dij.sagepub.com at SIMON FRASER LIBRARY on June 6, 2015
David A. Graves and Robert P. Baker
996
Health care professionals who become medical information providers within the pharmaceutical or biotechnology industry have accrued substantial knowledge and skills based upon their professional education, clinical training, and exper
Data Loading...
